Exercise for Patients With HIV Infections

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2009 by Charite University, Berlin, Germany.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT00910936
First received: May 29, 2009
Last updated: December 18, 2009
Last verified: December 2009

May 29, 2009
December 18, 2009
May 2009
January 2010   (final data collection date for primary outcome measure)
Maximal oxygen uptake (VO2max) [ Time Frame: At recruitment and after 12 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00910936 on ClinicalTrials.gov Archive Site
  • Quality of life [ Time Frame: At recruitment and after 12 weeks ] [ Designated as safety issue: No ]
  • Indicators of fat metabolism [ Time Frame: At recruitment and after 12 weeks ] [ Designated as safety issue: No ]
  • Markers of inflammation [ Time Frame: At recruitment and after 12 weeks ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Exercise for Patients With HIV Infections
Effects of an Exercise Program on Metabolic Parameters of Patients With a HIV Infection.

The investigators will evaluate the effects of an endurance exercise program on the physical performance, the well being, and indicators of metabolic function in patients with an HIV infection.

Not Provided
Interventional
Phase 2
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Supportive Care
  • HIV Infections
  • Lipodystrophy
  • Inflammation
Behavioral: Exercise
12 weeks endurance training, 3 times weekly for 35 minutes
  • Experimental: Intervention
    Intervention: Behavioral: Exercise
  • No Intervention: Control
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
60
February 2010
January 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 18 to 65
  • HIV infection
  • Antiviral therapy
  • Understanding of written German

Exclusion Criteria:

  • Diabetes mellitus
  • All conditions which can be aggravated by exercise
Both
18 Years to 65 Years
No
Contact: Fernando Dimeo, MD +493084452098 fernando.dimeo@charite.de
Germany
 
NCT00910936
EA04/050/07
No
Dr. Fernando Dimeo, Dept. of Sports Medicine, Charité Universitätsmedizin Berlin
Charite University, Berlin, Germany
Not Provided
Principal Investigator: Fernando Dimeo, MD Charite University, Berlin, Germany
Charite University, Berlin, Germany
December 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP